Developing a New MRI Technique to Understand Changes in Brain Tumors After Treatment
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorMemorial Sloan Kettering Cancer Center
About this trial
The purpose of this study is to develop and test a new magnetic resonance imaging (MRI) technique to see if it can be used to tell the difference between tumor growth from worsening of cancer and growth from the effects of treatment in participants who have brain tumors treated with radiation therapy called stereotactic radiosurgery (SRS).
Eligibility criteria
Qualifiers
Age ≥ 18 years
Able to understand and give informed consent
No known cancer diagnosis
Age ≥ 18 years
Disqualifiers
Pregnant or breastfeeding women
Pre-existing medical conditions, including the likelihood of developing seizures or claustrophobic reactions, and any greater than normal potential for cardiac arrest
Age < 18 years
Trial design
Treatments tested in this trial
- CEST-MRF
Treatment groups
119 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov